By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prothena Corporation plc 

25-28 North Wall Quay

  Dublin  1  Ireland
Phone: 353-1-902-3519 Fax: 353-1-902-3510



Company News
Prothena (PRTA) Soars on Positive Phase I Results Of Parkinson's Drug PRX002 3/20/2015 7:13:51 AM
Prothena Reports Fourth Quarter And Full Year 2014 Financial Results And Provides 2015 Financial Guidance And R&D Update 3/6/2015 7:50:02 AM
Prothena To Report Fourth Quarter And Full Year 2014 Financial Results And Host Webcast And Conference Call On March 5 2/20/2015 7:34:22 AM
Prothena To Present At The 2015 RBC Capital Markets' Healthcare Conference In New York On February 25 2/19/2015 7:55:09 AM
Prothena Receives FDA Fast Track Designation For NEOD001, A Monoclonal Antibody For The Treatment Of Patients With AL Amyloidosis 12/15/2014 10:53:45 AM
Prothena Corporation plc To Present At The Oppenheimer 25th Annual Healthcare Conference In New York 12/9/2014 12:26:33 PM
GUEST COLUMN: Does Size Kill Culture? Prothena Doesn’t Think So 12/8/2014 10:29:51 AM
Prothena Corporation plc Initiates NEOD001 Global Phase 3 Registrational Trial Based On Positive Results In Ongoing Phase 1/2 Study Of NEOD001 In Patients With AL Amyloidosis 12/3/2014 11:14:20 AM
Prothena Corporation plc CEO Diagnosed With Pancreatic Cancer 12/3/2014 8:27:30 AM
Prothena Corporation plc Targets Rare Protein-Misfolding Disease In Late-Stage Study 12/3/2014 7:01:29 AM